跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
沈 靜芬
副教授
小兒學科
https://orcid.org/0000-0001-5926-0462
電話
886 6 2353535 ext 4191
電子郵件
drshen
mail2000.com
tw
h-index
1618
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2025
每年研究成果
概覽
指紋
網路
專案
(12)
研究成果
(100)
類似的個人檔案
(6)
指紋
查看啟用 Ching-Fen Shen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Neutralizing Antibody
81%
COVID-19
72%
Influenza
46%
Viral Disease
38%
Omicron Coronavirus Variant
34%
Immunoassay
32%
Infectious Agent
32%
Virus
29%
Cytokine
28%
Humoral Immunity
25%
Interleukin 6
23%
Enzyme-Linked Immunosorbent Assay
22%
T Cell
21%
Procalcitonin
21%
Cross-Reactivity
21%
Blood Plasma
21%
Immunogenicity
20%
Immune Response
19%
TNF related apoptosis inducing ligand
18%
Receptor Binding
17%
Neutralization
16%
RNA Sequence
16%
Spike
15%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
15%
Interferon
15%
Antibody Response
15%
CD8
14%
Booster Dose
14%
Microorganism Detection
14%
Maternal Blood
13%
Influenza Virus
13%
Lateral Flow Assay
13%
Memory T Cell
13%
Urinary Tract
13%
Innate Immune System
12%
Inflammatory Cytokine
12%
Adoptive Immunity
11%
Maternal Serum
11%
Enterovirus A71
10%
Platelet
10%
Adeno Associated Virus 2
10%
Staphylococcus aureus
10%
Influenzavirus A
10%
Influenza A Virus (H1N1)
10%
Parainfluenza Virus
10%
Pneumococcal Vaccine
10%
Stenotrophomonas maltophilia
10%
Pertussis Vaccine
10%
Escherichia coli
10%
Medicine and Dentistry
COVID-19
54%
Diseases
44%
Interleukin 6
43%
Biological Marker
43%
Infection
39%
Severe Acute Respiratory Syndrome Coronavirus 2
38%
Pneumococcus Vaccine
33%
Emergency Department
32%
Bacterial Infection
28%
Cytokine
26%
Neutralizing Antibody
24%
Pediatrics
24%
Community-Acquired Pneumonia
23%
Enzyme Linked Immunosorbent Assay
23%
Observational Study
23%
Pathogen
23%
Virus Infection
23%
Virus
22%
Immunoassay
21%
Pneumococcal Pneumonia
21%
Streptococcus pneumonia
21%
Mycoplasma Pneumonia
21%
Respiratory Failure
21%
Serositis
19%
Pneumococcal Infection
16%
Cohort Effect
14%
Encephalitis
13%
COVID-19 Vaccine
13%
COVID-19 Diagnosis
13%
Influenza B
12%
Neurologic Disease
11%
Fulminant
10%
Coronavirinae
10%
Childhood Tuberculosis
10%
T-Cell Response
10%
Macrolide
10%
Messenger RNA
10%
Enterovirus A71
10%
Letermovir
10%
Acute Leukemia
10%
Serotype
10%
Parainfluenza Virus
10%
Inflammatory Disorder
10%
Influenza Virus
10%
Triage
10%
Human Adenovirus C
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Pediatric Infection
10%
Laboratory Diagnosis
10%
Urinary System
10%
Keyphrases
Taiwan
36%
Pregnant Women
32%
COVID-19
25%
Infections in children
21%
Neutralizing Antibodies
21%
Spectrum-based Optical Reader
21%
Influenza Severity
21%
Influenza B
19%
Antibody Inhibition
14%
Vaccination
13%
COVID-19 Vaccine
13%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
12%
Boar Sperm
10%
Pregnancy Infections
10%
Transplacental Antibody Transfer
10%
Children at Risk
10%
Encephalitis
10%
Adolescent Experiences
10%
COVID-19 Vaccination
10%
Vaccine Effectiveness
10%
Virus
10%
COVID-19 Diagnosis
10%
Paper-based Immunoassay
10%
BNT162b2 Vaccine
10%
Memory T Cell Response
10%
Cytokine Profiling
10%
ChAdOx1 nCov-19 Vaccination
10%
Apologizing
10%
Microglial Inflammation
10%
Virus Infection
10%
Full Immunization
10%
7-valent
10%
BQ.1.1
10%
Omicron Infection
10%
Pneumococcal Vaccine
10%
Bivalent Boosters
10%
PCV7
10%
Long-term Characteristics
10%
Glycoproteomics
10%
BF.7
10%
Omicron BA.5
10%
XBB.1.5
10%
Invasive Pneumococcal Disease
10%
Letermovir
10%
Gram-negative Bacteria Infection
10%
Acute Leukemia
10%
Pertussis Vaccine
10%
Response to Infection
10%
Antenatal Vaccination
10%
Socioeconomic Factors
10%
